REPORT ID 1088

Global Cancer Diagnostics Sales Market Report 2017

Publish Date
05-Dec-17
Pages
105
Format
Electronic (PDF)

In this report, the global Cancer Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Cancer Diagnostics for these regions, from 2012 to 2022 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Cancer Diagnostics market competition by top manufacturers/players, with Cancer Diagnostics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    C.R. Bard, Inc.
    GE Healthcare
    Becton, Dickinson and Company
    Abbott
    Roche
    Thermo Fisher Scientific
    Agilent Technologies
    Siemens Healthcare
    Illumina
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diagnostic Reagent
    Diagnostic Instrument
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Breast Cancer
    Lung Cancer
    Colorectal Cancer
    Melanoma
    Other Cancers

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Cancer Diagnostics Sales Market Report 2017
1 Cancer Diagnostics Market Overview
    1.1 Product Overview and Scope of Cancer Diagnostics
    1.2 Classification of Cancer Diagnostics by Product Category
        1.2.1 Global Cancer Diagnostics Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 Global Cancer Diagnostics Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Diagnostic Reagent
        1.2.4 Diagnostic Instrument
    1.3 Global Cancer Diagnostics Market by Application/End Users
        1.3.1 Global Cancer Diagnostics Sales (Volume) and Market Share Comparison by Application (2012-2022)
        1.3.2 Breast Cancer
        1.3.3 Lung Cancer
        1.3.4 Colorectal Cancer
        1.3.5 Melanoma
        1.3.6 Other Cancers
    1.4 Global Cancer Diagnostics Market by Region
        1.4.1 Global Cancer Diagnostics Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 United States Cancer Diagnostics Status and Prospect (2012-2022)
        1.4.3 China Cancer Diagnostics Status and Prospect (2012-2022)
        1.4.4 Europe Cancer Diagnostics Status and Prospect (2012-2022)
        1.4.5 Japan Cancer Diagnostics Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Cancer Diagnostics Status and Prospect (2012-2022)
        1.4.7 India Cancer Diagnostics Status and Prospect (2012-2022)
    1.5 Global Market Size (Value and Volume) of Cancer Diagnostics (2012-2022)
        1.5.1 Global Cancer Diagnostics Sales and Growth Rate (2012-2022)
        1.5.2 Global Cancer Diagnostics Revenue and Growth Rate (2012-2022)

2 Global Cancer Diagnostics Competition by Players/Suppliers, Type and Application
     2.1 Global Cancer Diagnostics Market Competition by Players/Suppliers
        2.1.1 Global Cancer Diagnostics Sales and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Global Cancer Diagnostics Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Global Cancer Diagnostics (Volume and Value) by Type
        2.2.1 Global Cancer Diagnostics Sales and Market Share by Type (2012-2017)
        2.2.2 Global Cancer Diagnostics Revenue and Market Share by Type (2012-2017)
    2.3 Global Cancer Diagnostics (Volume and Value) by Region
        2.3.1 Global Cancer Diagnostics Sales and Market Share by Region (2012-2017)
        2.3.2 Global Cancer Diagnostics Revenue and Market Share by Region (2012-2017)
    2.4 Global Cancer Diagnostics (Volume) by Application

3 United States Cancer Diagnostics (Volume, Value and Sales Price)
    3.1 United States Cancer Diagnostics Sales and Value (2012-2017)
        3.1.1 United States Cancer Diagnostics Sales and Growth Rate (2012-2017)
        3.1.2 United States Cancer Diagnostics Revenue and Growth Rate (2012-2017)
        3.1.3 United States Cancer Diagnostics Sales Price Trend (2012-2017)
    3.2 United States Cancer Diagnostics Sales Volume and Market Share by Players
    3.3 United States Cancer Diagnostics Sales Volume and Market Share by Type
    3.4 United States Cancer Diagnostics Sales Volume and Market Share by Application

4 China Cancer Diagnostics (Volume, Value and Sales Price)
    4.1 China Cancer Diagnostics Sales and Value (2012-2017)
        4.1.1 China Cancer Diagnostics Sales and Growth Rate (2012-2017)
        4.1.2 China Cancer Diagnostics Revenue and Growth Rate (2012-2017)
        4.1.3 China Cancer Diagnostics Sales Price Trend (2012-2017)
    4.2 China Cancer Diagnostics Sales Volume and Market Share by Players
    4.3 China Cancer Diagnostics Sales Volume and Market Share by Type
    4.4 China Cancer Diagnostics Sales Volume and Market Share by Application

5 Europe Cancer Diagnostics (Volume, Value and Sales Price)
    5.1 Europe Cancer Diagnostics Sales and Value (2012-2017)
        5.1.1 Europe Cancer Diagnostics Sales and Growth Rate (2012-2017)
        5.1.2 Europe Cancer Diagnostics Revenue and Growth Rate (2012-2017)
        5.1.3 Europe Cancer Diagnostics Sales Price Trend (2012-2017)
    5.2 Europe Cancer Diagnostics Sales Volume and Market Share by Players
    5.3 Europe Cancer Diagnostics Sales Volume and Market Share by Type
    5.4 Europe Cancer Diagnostics Sales Volume and Market Share by Application

6 Japan Cancer Diagnostics (Volume, Value and Sales Price)
    6.1 Japan Cancer Diagnostics Sales and Value (2012-2017)
        6.1.1 Japan Cancer Diagnostics Sales and Growth Rate (2012-2017)
        6.1.2 Japan Cancer Diagnostics Revenue and Growth Rate (2012-2017)
        6.1.3 Japan Cancer Diagnostics Sales Price Trend (2012-2017)
    6.2 Japan Cancer Diagnostics Sales Volume and Market Share by Players
    6.3 Japan Cancer Diagnostics Sales Volume and Market Share by Type
    6.4 Japan Cancer Diagnostics Sales Volume and Market Share by Application

7 Southeast Asia Cancer Diagnostics (Volume, Value and Sales Price)
    7.1 Southeast Asia Cancer Diagnostics Sales and Value (2012-2017)
        7.1.1 Southeast Asia Cancer Diagnostics Sales and Growth Rate (2012-2017)
        7.1.2 Southeast Asia Cancer Diagnostics Revenue and Growth Rate (2012-2017)
        7.1.3 Southeast Asia Cancer Diagnostics Sales Price Trend (2012-2017)
    7.2 Southeast Asia Cancer Diagnostics Sales Volume and Market Share by Players
    7.3 Southeast Asia Cancer Diagnostics Sales Volume and Market Share by Type
    7.4 Southeast Asia Cancer Diagnostics Sales Volume and Market Share by Application

8 India Cancer Diagnostics (Volume, Value and Sales Price)
    8.1 India Cancer Diagnostics Sales and Value (2012-2017)
        8.1.1 India Cancer Diagnostics Sales and Growth Rate (2012-2017)
        8.1.2 India Cancer Diagnostics Revenue and Growth Rate (2012-2017)
        8.1.3 India Cancer Diagnostics Sales Price Trend (2012-2017)
    8.2 India Cancer Diagnostics Sales Volume and Market Share by Players
    8.3 India Cancer Diagnostics Sales Volume and Market Share by Type
    8.4 India Cancer Diagnostics Sales Volume and Market Share by Application

9 Global Cancer Diagnostics Players/Suppliers Profiles and Sales Data
    9.1 C.R. Bard, Inc.
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Cancer Diagnostics Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 C.R. Bard, Inc. Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.1.4 Main Business/Business Overview
    9.2 GE Healthcare
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Cancer Diagnostics Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 GE Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.2.4 Main Business/Business Overview
    9.3 Becton, Dickinson and Company
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Cancer Diagnostics Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Becton, Dickinson and Company Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.3.4 Main Business/Business Overview
    9.4 Abbott
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Cancer Diagnostics Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Abbott Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.4.4 Main Business/Business Overview
    9.5 Roche
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Cancer Diagnostics Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Roche Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.5.4 Main Business/Business Overview
    9.6 Thermo Fisher Scientific
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Cancer Diagnostics Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Thermo Fisher Scientific Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.6.4 Main Business/Business Overview
    9.7 Agilent Technologies
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Cancer Diagnostics Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Agilent Technologies Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.7.4 Main Business/Business Overview
    9.8 Siemens Healthcare
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Cancer Diagnostics Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Siemens Healthcare Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.8.4 Main Business/Business Overview
    9.9 Illumina
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Cancer Diagnostics Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Illumina Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2012-2017)
        9.9.4 Main Business/Business Overview

10 Cancer Diagnostics Maufacturing Cost Analysis
    10.1 Cancer Diagnostics Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Cancer Diagnostics
    10.3 Manufacturing Process Analysis of Cancer Diagnostics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Cancer Diagnostics Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Cancer Diagnostics Major Manufacturers in 2016
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Cancer Diagnostics Market Forecast (2017-2022)
    14.1 Global Cancer Diagnostics Sales Volume, Revenue and Price Forecast (2017-2022)
       14.1.1 Global Cancer Diagnostics Sales Volume and Growth Rate Forecast (2017-2022)
       14.1.2 Global Cancer Diagnostics Revenue and Growth Rate Forecast (2017-2022)
       14.1.3 Global Cancer Diagnostics Price and Trend Forecast (2017-2022)
    14.2 Global Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
       14.2.1 Global Cancer Diagnostics Sales Volume and Growth Rate Forecast by Regions (2017-2022)
       14.2.2 Global Cancer Diagnostics Revenue and Growth Rate Forecast by Regions (2017-2022)
       14.2.3 United States Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.4 China Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.5 Europe Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.6 Japan Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.7 Southeast Asia Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
       14.2.8 India Cancer Diagnostics Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
    14.3 Global Cancer Diagnostics Sales Volume, Revenue and Price Forecast by Type (2017-2022)
       14.3.1 Global Cancer Diagnostics Sales Forecast by Type (2017-2022)
       14.3.2 Global Cancer Diagnostics Revenue Forecast by Type (2017-2022)
       14.3.3 Global Cancer Diagnostics Price Forecast by Type (2017-2022)
    14.4 Global Cancer Diagnostics Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer